Medical Doctor Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Allen O'Barr

Psychiatry Chapel Hill, NC Medical Doctor

NPI 1972610129 CMS profile 903263

902 Dawes St, Chapel Hill, NC 27516

Open in the dashboard

General payments

$4,395

269 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Allen O'Barr of Chapel Hill, NC is reported in the CMS Open Payments database as having received $4,395 across 269 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 87th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $246 14
2024 General $1,069 69
2023 General $1,273 74
2022 General $1,640 102
2021 General $167 10

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Allen O'Barr
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Allen O'Barr were reported at $246. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Allen O'Barr Psychiatry median Middle half National median
2019 $0 $184 $59–$605 $163
2020 $0 $119 $36–$372 $114
2021 $167 $143 $43–$576 $132
2022 $1,640 $153 $50–$590 $149
2023 $1,273 $170 $56–$651 $160
2024 $1,069 $179 $57–$673 $164
2025 $246 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $774 65 payments
  2. Supernus Pharmaceuticals, Inc. $656 29 payments
  3. Janssen Pharmaceuticals, Inc $356 20 payments
  4. ITI, Inc. $347 21 payments
  5. Corium, Inc. $234 14 payments
  6. Otsuka America Pharmaceutical, Inc. $229 12 payments
  7. Bausch Health US, LLC $218 13 payments
  8. Lundbeck LLC $194 10 payments
  9. Teva Pharmaceuticals USA, Inc. $190 14 payments
  10. Idorsia Pharmaceuticals US Inc $161 10 payments
  11. Other $1,037 61 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $4,395 269 payments
Products named General payments · program years 2021–2025
  1. QELBREE $639 28 payments
  2. VRAYLAR $391 36 payments
  3. SPRAVATO $356 20 payments
  4. CAPLYTA $290 19 payments
  5. UBRELVY $253 19 payments
  6. Azstarys $234 14 payments
  7. APLENZIN $218 13 payments
  8. REXULTI $199 10 payments
  9. QULIPTA $177 15 payments
  10. QUVIVIQ $161 10 payments
  11. Other $2,047 121 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 13 drugs

Part D claims

323

Median for Psychiatry: 574

Drug cost

$17,533

Median for Psychiatry: $27,624

Branded share of claims

22.6%

Median for Psychiatry: 17%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Aripiprazole Generic 23 $11,638
Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine Brand 61 $2,527
Lamotrigine Generic 33 $609
Methylphenidate Hcl Generic 13 $536
Lorazepam Generic 19 $514
Dexmethylphenidate Hcl Generic 11 $477
Clonazepam Generic 60 $379
Quetiapine Fumarate Generic 19 $290
Bupropion Xl Bupropion Hcl Brand 12 $225
Fluoxetine Hcl Generic 17 $110

The 10 drugs with the highest cost, of 13 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 20,488 Part D prescribers listed as Psychiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 5 billing codes

Paid by Medicare

$2,947

Medicare's payments for the services billed

Medicare patients

13

Average age 66

Services billed

40

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Heart failure 0%
Atrial fibrillation 0%
COPD 0%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 21 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
VRAYLAR
  • AbbVie, Inc. $117
$117 — —
SPRAVATO
  • Janssen Pharmaceuticals, Inc $116
$116 — —
CAPLYTA
  • ITI, Inc. $108
$108 — —
REXULTI
  • Otsuka America Pharmaceutical, Inc. $68
  • Lundbeck LLC $15
$83 — —
Azstarys
  • Corium, Inc. $72
$72 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 21 in the dashboard with a free account

Records

269 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record